In recognition of the sparse information available to practitioners in the field of business development, Martin Austin has drawn on his 30 years of experience in the pharmaceutical industry to provide this highly practical guide spanning the complete process. Based on the well-established training programme he has developed and delivers to pharmaceutical executives from across the world, this book will help expand your knowledge in this immense area.
Onetti and Zucchella begin by unpacking the often-used ‘business model’ term, examining key elements of business model conceptualization and offering a three tier approach with a clear separation between the business model and strategy: ...
Moreover, they have done so with much lower overall costs. From Breakthrough to Blockbuster: The Business of Biotechnology focuses on both the companies themselves and the broader biotech ecosystem that supports them.
Offers detailed information on over one hundred careers in such areas as regulatory affairs, product development, information management, and sales.
The present work by Yali Friedman is set out to bring together a set of best practices to be used as a framework upon which to understand critical issues in biotechnology business development.
Inside the Minds: Biotechnology Deals is an authoritative, insider's perspective on the issues surrounding biotech deals, including mergers and acquisitions, collaborations, and the future of doing successful deals. Featuring lawyers,...
Protection (and maintenance) of a second copy should be a provision of the IT disaster recovery plan in the case of catastrophic loss of the computing facilities even if the files are particularly sensitive data encryption should be ...
In this book you will find practical answers to: Why does it take so long to develop a biotechnology product? What is involved in making a therapeutic or diagnostic? How much money is needed to develop a product idea from bench to bedside?
4 (Winter 2007): 640–60. Siler, Kyle, Kirby Lee, and Lisa Bero. “Measuring the Effectiveness of Scientific Gatekeeping.” Proceedings of the National Academy of Sciences 112, no. 2 (January 2015): 360–65. Silva, Olmo.
Academics working on innovation and biotechnology, as well as scientists engaged in research in the life sciences, will also find this book of particular interest.
T. Staton, “AstraZeneca Steps Up Its Global Restructuring with 550 New Job Cuts,” FiercePharma, 6 February 2014, http://www.fiercepharma.com/story/astrazeneca -steps-its-global-restructuring-550-new-job-cuts/2014-02-06. 104.